Tivicay
Positive Initial Results From Twin GEMINI Studies Signal Hope for 2-Drug Strategy in HIV
There is reason for cautious optimism that HIV regimens can be simplified without sacrificing safety or efficacy, ...
SEPTEMBER 21, 2018
FDA Warns of Neural Tube Birth Defects With Dolutegravir
The FDA issued an alert about serious cases of neural tube birth defects involving the brain, spine and spinal cord ...
MAY 18, 2018
FDA Approves Juluca, First 2-Drug Regimen for HIV
Juluca is the first complete treatment regimen containing only two drugs for the maintenance treatment of HIV-1 ...
NOVEMBER 22, 2017
2-Drug Combination Effective in Maintaining Viral Suppression in HIV Patients
The requirement of lifelong treatment for HIV infection has highlighted a need to minimize cumulative drug ...
FEBRUARY 17, 2017
Load more